Live Oak Health Sciences holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Live Oak Health Sciences Fund LOGSX
- NAV / 1-Day Return $27.17 / −1.20 %
- Fund Size $66.4M
- Adjusted Expense Ratio 1.040%
- Net Expense Ratio 1.040%
- Fee Level: Distribution Above Average
- Share Class Type Institutional
- Morningstar Category Health
- Equity Style Box (Funds) Mid Value
- Minimum Initial Investment $2,000
- Investment Status Open
- TTM Yield 0.09%
- Turnover Ratio 24%
Morningstar’s Analysis LOGSX
Will LOGSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Prime 3.53 10/1/26 | 6.20 | 4M | — |
Cardinal Health Inc | 5.22 | 3M | Healthcare |
Exelixis Inc | 5.03 | 3M | Healthcare |
United Therapeutics Corp | 4.93 | 3M | Healthcare |
Amgen Inc | 4.90 | 3M | Healthcare |
Jazz Pharmaceuticals PLC | 4.87 | 3M | Healthcare |
Lantheus Holdings Inc | 4.30 | 3M | Healthcare |
McKesson Corp | 4.17 | 3M | Healthcare |
Regeneron Pharmaceuticals Inc | 4.06 | 2M | Healthcare |
Cencora Inc | 3.96 | 2M | Healthcare |